Derivative exercise or conversion — not an open-market buy.
Traded Mar 18, 2026 · Filed Mar 19, 2026
Docusign's President General Mgr, Growth sold $64K of Docusign shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$63,500
Shares × reported transaction price
1 day after results of Mar 17, 2026, 78 days before results of Jun 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.2% | −2.2% | −1.0% |
| 30 days | +1.0% | +9.3% | −8.3% |
| 90 days | −8.0% | +15.1% | −23.1% |
| 180 days | +49.1% | +16.3% | +32.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of Docusign sold $144K of Docusign shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.